Abstract
There are currently no intramammary antimicrobial products labeled for use in goats in the United States. However, both clinical and subclinical mastitis impart heavy production losses to this growing sector of American agriculture annually. Subclinical mastitis can be particularly insidious by causing unrealized production losses and dry off is an ideal time to detect and manage cases using long-acting intramammary antimicrobial therapy. The goal of this study was to determine milk residue depletion times for 2 such antimicrobials in dairy goats in the immediate post-fresh period.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: American Association of Bovine Practitioners Conference Proceedings
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
